Schneider Membrane Preservation With In Situ Osteogenesis: A Modified Maxillary Resection Study
1 other identifier
interventional
18
1 country
1
Brief Summary
This case series study aimed to find out if a new surgical technique that preserves the sinus membrane during upper jaw removal can help patients regenerate bone and recover function better after surgery. The study included two female patients with jaw tumors who were not suitable for or did not want complex reconstruction with tissue flaps. The main questions the study tried to answer were: Can the preserved sinus membrane help new bone grow spontaneously in the jaw defect area after surgery? Can this new method reduce common complications seen with traditional surgery, such as oronasal fistula and empty nose syndrome? How well can patients recover in terms of chewing, swallowing, speech, and quality of life after the procedure? In the study, during surgery, the surgeon carefully separated and preserved the sinus membrane from the bone that needed to be removed. After surgery, patients were followed with regular CT scans to check new bone growth. They also underwent tests to measure chewing force, swallowing ability, speech function, and quality of life to evaluate the long-term outcomes of this technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 10, 2026
January 27, 2026
January 1, 2026
1.1 years
December 22, 2025
January 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Bone regeneration status
Patients were followed up at 1, 3, and 6 months to assess bone formation in the maxillary sinus floor (CT slices used the contralateral first maxillary molar in the surgical area as an anatomical reference for preoperative and postoperative comparison). Specifically, the Planmeca ProMax® 3D tool was used to evaluate bone regeneration, measuring the length in the coronal plane, the length in the sagittal plane, and the height (in mm) on CT scans. The volume of newly formed maxillary sinus floor bone (in cubic millimeters) was calculated to assess the newly generated bone in the maxillary sinus floor.
6 months
Secondary Outcomes (1)
Postoperative complications
1 year
Study Arms (2)
Traditional Procedure Group
NO INTERVENTIONModified Procedure Group
ACTIVE COMPARATORInterventions
1\. Perform preoperative imaging evaluation of the patient to observe the condition of the maxillary sinus bony walls. During surgery, flap the tissue to expose the anterior wall of the maxilla, and create a window in the normal bone area of the anterior wall (approximately 10×15mm in diameter); 5. Carefully insert the maxillary sinus elevation instrument between the maxillary sinus membrane and the maxilla, delicately separate the maxillary sinus membrane while maintaining its integrity, and elevate the membrane to the required height. 6\. Place a wet gauze between the elevated membrane and the maxilla to protect the Schneiderian membrane, use an ultrasonic osteotome or reciprocating saw to remove the pathological tissue, and confirm negative margins intraoperatively with frozen section.
Eligibility Criteria
You may qualify if:
- Maxillary lesions requiring resection of the jaw as diagnosed by imaging (CT) and pathology;
- CT shows the lesion only invades the maxilla without involving the maxillary sinus cavity;
- No nasal septum within the maxillary sinus cavity, with an intact and smooth sinus floor bone wall;
- No distant metastatic malignant tumors;
- American Society of Anesthesiologists (ASA) classification I-III, able to tolerate general anesthesia.
You may not qualify if:
- Lesions invading the maxillary sinus mucosa;
- Presence of septa or severe inflammation in the maxillary sinus;
- Previous history of head and neck radiotherapy;
- Coexisting immune system diseases or metabolic bone diseases;
- Pregnancy or breastfeeding;
- Any surgical contraindications;
- Mental illness or inability to comply with follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wenzhao Guanlead
Study Sites (1)
The Second Hospital of Shanxi Medical University
Shanxi, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
December 22, 2025
First Posted
January 6, 2026
Study Start
May 1, 2025
Primary Completion (Estimated)
June 8, 2026
Study Completion (Estimated)
June 10, 2026
Last Updated
January 27, 2026
Record last verified: 2026-01